The First People's Hospital of Yunan Province Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Kunming China (1939)

Organization Overview

First Clinical Trial
2006
NCT00615667
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of nephrology, People's Hospital of Yunnan Province | People's Hospital of Yunnan Province | The Cancer Hospital of Yunnan，Kunming, Yunnan, China | The First People's Hospital of Yunan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital | The First People's Hospital of Yunnan | The First People's Hospital of Yunnan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital | Yunnan First People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

beta-Thalassemia (Phase 4)

Dwarfism, Pituitary (Phase 4)

Endocrine System Diseases (Phase 4)

Glomerulonephritis, IGA (Phase 3)

Kidney Diseases (Phase 3)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lupus Nephritis (Phase 4)

Neoplasms (Phase 1)

Nephritis (Phase 4)

Nephrosis (Phase 3)

Nephrotic Syndrome (Phase 3)

Parkinson Disease (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Syndrome (Phase 3)

Thalassemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 31